Sunday, July 21, 2013

Question of the Day July 21, 2013 What Action Should the FDA and State Boards of Pharmacies Be Taking Against the Makers of Purple Pain and TB-500 in ligh t of the Racing Medication and Testing Consortium finding these are unclassified medications that will be regarded as high-level violations if used in racing? Who is the company producing these drugs? How Many of these Products are being sold in the United States?

Background as previously posted:  The Racing Medication and Testing Consortium has noted that two substances available only through compounding pharmacies are unclassified medications that will be regarded as high-level violations if used in racing. 

 Purple Pain is marketed as a pain reliever. TB-500 is claimed by some marketing materials to build muscle, speed muscle recovery, stop bleeding, increase red blood cells, and decrease inflammation.

Read more on BloodHorse.com: http://www.bloodhorse.com/horse-racing/articles/79187/stiff-penalties-tied-to-purple-pain-tb-500#ixzz2ZezcLpNL



Post a Comment